Four HBP-related genes (GFPT, GNPNAT, PGM3, and UAP1) can be used to guide immunologic and targeted therapies for osteosarcoma, with significant predictive value for osteosarcoma prognosis (Su et al., 2022). The gene discussed is GFPT1; the disease is osteosarcoma.